The senegalese authorities said Sunday their intention to continue to prescribe hydroxychloroquine to the sick of the COVID-19 after a preliminary analysis showing a reduction in the duration of hospitalization, while the country is facing a constant increase of cases.
They have also, before this increase continues, announced their decision not to hospitalize routinely in patients who have no or few symptoms, but the isolate in open sites, in order to relieve the hospitals.
They have also decided on Saturday night to close the markets of Dakar, Saturday and Sunday, and to reduce their frequency by week.
The health authorities have officially declared 1.115 contamination cases and nine deaths in the last two months since the confirmation of the virus ‘ appearance on march 2, according to a new balance sheet reported Sunday.
“The major finding is that the epidemic does not weaken “, has told the press the minister of Health, Abdoulaye Diouf Sarr.
He said that the pandemic remained under control. But he stressed that in a month the number of cases has ” more than quintupled “, and that transmission occurs more by a way more worrying and the so-called community, that is to say, without any established link between the new cases and those already identified.
In the Face of the pandemic, Senegal has early made the choice to follow the example of the French professor Didier Raoult, and to generalize the prescription, in a hospital, hydroxychloroquine, antimalarial drug available on the market, in the heart of a quarrel of international experts as to its efficacy and safety.
Professor Moussa Seydi, infectious diseases physician who coordinates the care of contaminated, Senegal, presented the results of the analysis “preliminary” showing that out of 181 patients, the median duration of hospitalization was 13 days for patients who received no treatment, 11 for those who received hydroxychloroquine alone, 9 for those who received hydroxychloroquine associated with azithromycin (an antibiotic), and even 8 for those who have consulted early and started the treatment within 24 hours.
According to this analysis focused on 362 subjects, side-effects, not otherwise specified, were observed in 12 persons, he said. The treatment was maintained for 4 of them because the effects were not ” troublesome “, and stopped for the other 8, but there has been “no serious side effects” and all the signs have regressed, at the end of the treatment, he reported.
“Given these preliminary results, we will continue our support with hydroxychloroquine “, he said.